Background: Familial hypercholesterolemia (FH) is associated with premature
atherosclerotic cardiovascular disease caused by elevated low-density lipoprotein …

Lead Author's Financial Disclosures Nothing to disclose. Study Funding None.
Background/Synopsis Familial Hypercholesterolemia (FH) is the most common genetic …

Introduction: Genetic testing for familial hypercholesterolaemia (FH) is not yet established for
widespread use internationally to provide diagnostic confirmation, in part due to high cost …

Background and aims It is unclear to what extent genetic testing improves the ability to
diagnose familial hypercholesterolaemia (FH). We investigated the percentage with FH …

BACKGROUND Familial Hypercholesterolemia (FH) is the most common genetic disorder in
humans with an estimated prevalence of 1/311. In geographic regions with founder effect …

Methods: 300 unrelated patients of Swedish origin with clinical suspicion of heterozygous
FH, scored according to the Dutch Lipid Clinics Network (DLCN) criteria, were analyzed …

Background Familial hypercholesterolemia (FH) is a common genetic disorder resulting in
high levels of low-density lipoprotein cholesterol and increased risk of atherosclerotic …

Background: Familial Hypercholesterolemia (FH) is associated with premature
atherosclerotic cardiovascular disease caused by excessive accumulation of LDL-C in …

Familial hypercholesterolemia (FH) is a monogenic disease characterized by a lifelong
exposure to high LDL-C levels that can lead to early onset coronary heart disease (CHD) …

Background Familial hypercholesterolemia (FH) is an autosomal dominant genetic disease,
causing dyslipidemia and premature atherosclerotic cardiovascular disease (ASCVD), with …